Urine Nuclear Magnetic Resonance (NMR) Metabolomics in Age-Related Macular Degeneration
authors Lains, I; Duarte, D; Barros, AS; Martins, AS; Carneiro, TJ; Gil, JQ; Miller, JB; Marques, M; Mesquita, TS; Barreto, P; Kim, IK; Cachulo, MD; Vavvas, DG; Carreira, IM; Murta, JN; Silva, R; Miller, JW; Husain, D; Gil, AM
nationality International
journal JOURNAL OF PROTEOME RESEARCH
author keywords age-related macular degeneration; urine; metabolomics; nuclear magnetic resonance spectroscopy
keywords SIGNATURES; SPECTROSCOPY; DISEASE; PLASMA; METABONOMICS; PREVALENCE; VALIDATION; DIAGNOSIS; REVEALS; CANCER
abstract Biofluid biomarkers of age-related macular degeneration (AMD) are still lacking, and their identification is challenging. Metabolomics is well-suited to address this need, and urine is a valuable accessible biofluid. This study aimed to characterize the urinary metabolomic signatures of patients with different stages of AMD and a control group (>50 years). It was a prospective, cross-sectional study, where subjects from two cohorts were included: 305 from Coimbra, Portugal (AMD patients n = 252; controls n = 53) and 194 from Boston, United States (AMD patients n = 147; controls n = 47). For all participants, we obtained color fundus photographs (for AMD staging) and fasting urine samples, which were analyzed using 1H nuclear magnetic resonance (NMR) spectroscopy. Our results revealed that in both cohorts, urinary metabolomic profiles differed mostly between controls and late AMD patients, but important differences were also found between controls and subjects with early AMD. Analysis of the metabolites responsible for these separations revealed that, even though distinct features were observed for each cohort, AMD was in general associated with depletion of excreted citrate and selected amino acids at some stage of the disease, suggesting enhanced energy requirements. In conclusion, NMR metabolomics enabled the identification of urinary signals of AMD and its severity stages, which might represent potential metabolomic biomarkers of the disease.
publisher AMER CHEMICAL SOC
issn 1535-3893
year published 2019
volume 18
issue 3
beginning page 1278
ending page 1288
digital object identifier (doi) 10.1021/acs.jproteome.8b00877
web of science category Biochemical Research Methods
subject category Biochemistry & Molecular Biology
unique article identifier WOS:000460491800042

Sponsors

1suponsers_list_ciceco.jpg